Sysmex Preparing to Move New Molecular Assays to Market

Molecular diagnostics has the same potential to create new winners and new losers among in vitro diagnostics (IVD) manufacturers as it does to clinical labs and pathology groups. New molecular assays with the ability to dramatically improve the detection of disease and guide physicians to identify the most effective therapy for individual patients, can radically change the existing market status quo. One example of how molecular tests can open new markets for established IVD vendors is the...

A Tale of Two Analyzers and Other Thoughts from AACC 2008

There were plenty of new and interesting analyzers, lab tests, and other products on display this week in Washington, DC, at the exhibition during the annual meeting of the American Association of Clinical Chemistry (AACC). Dark Daily was there to take it all in and to identify emerging trends in laboratory and pathology management. There were new instrument systems galore, because many in vitro diagnostics (IVD) manufacturers use the AACC exhibition as the place to unveil their latest...
;